Prof. Dr. Med. Patrick Hunziker


Deputy Head of the Clinic for
Intensive Care Medicine

University / Hospital Affiliation

University Hospital Basel


Prof. Patrick Hunziker, MD is a physician and scientist working at the University Hospital of Basel, Switzerland, in the position of Deputy Head of the Clinic for Intensive Care Medicine. After medical studies at the University of Zurich, he wrote a doctoral thesis in experimental immunology, and he specialized in Internal Medicine, Cardiology and Intensive Care Medicine including fellowships at the University Hospital of Basel, University of Geneva (Switzerland), and the Massachusetts General Hospital (Boston, U.S.). His scientific and medical experience includes professional work in Europe, the U.S., China and Africa. He was awarded a professorship at the University of Basel, Switzerland based on research in computer vision in cardiology. Starting in the late 90s, he started activities in Nanomedicine, and founded, together with Beat Loeffler, Dr. med.h.c. the nonprofit CLINAM Foundation for Clinical Nanomedicine to advance the application of nanoscience in medicine. He is founding president of the International Society for Nanomedicine. His current research integrates nanoscience (microfluidics, intelligent nanomaterials), embedded high-performance computing, and computational modeling from nano to macro to physiology, with the aim to contribute to the progress of medicine for the benefit of patients and society. His 200 papers have been cited 8000 times; he helped shape spin-off companies out of his research group and is author of a number of patents.

Related Content

Manuscripts & Publications

Left ventricular unloading and the role of ECpella

The main reason for the emergency implantation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) is the restoration of adequate systemic perfusion, while protecting the failing heart and promoting myocardial recovery are equally important goals.

Atherosclerosis: Insights into Vascular Pathobiology and Outlook to Novel Treatments

The pathobiology of atherosclerosis and its current and potential future treatments are summarized, with a spotlight on three central cell types involved: (i) endothelial cells (ECs), (ii) macrophages, and (iii) vascular smooth muscle cells (VSMCs).

Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock – A European experienced users working group opinion

For patients with myocardial infarct-related cardiogenic shock (CS), urgent percutaneous coronary intervention is the recommended treatment strategy to limit cardiac and systemic ischemia. However, a specific therapeutic intervention is often missing in non-ischemic CS cases.